Tourmaline Bio, Inc. (TRML)

47.98 0.00 (0.00%) USD  |  NASDAQ  |  Dec 09, 16:00
More

Tourmaline Bio EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for TRML.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Novartis AG Upgrade
Merck & Co., Inc. Upgrade
UnitedHealth Group, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Eli Lilly & Co. Upgrade